PRESS RELEASE published on 03/26/2025 at 19:31, 1 year 3 months ago EQS-Adhoc: H&R GmbH & Co. KGaA: Postponement of the publication of the consolidated financial statements and the annual report 2024 H&R GmbH & Co. KGaA postpones publication of 2024 financial statements & annual report due to accounting complexities of Climate Protection Agreement. No impact on earnings expected Annual Report H&R GmbH & Co. KGaA Postponement 2024 Financial Statements Climate Protection Agreement
BRIEF published on 02/27/2025 at 13:13, 1 year 4 months ago H&R GmbH Reports Resilient Preliminary Results for 2024 Sales Revenue EBITDA Increase Financial Growth H&R GmbH Preliminary Results 2024
BRIEF published on 02/27/2025 at 13:13, 1 year 4 months ago H&R GmbH publie des résultats préliminaires solides pour 2024 Chiffre D'affaires Croissance Financière Augmentation De L'EBITDA H&R GmbH Résultats Préliminaires 2024
PRESS RELEASE published on 02/27/2025 at 13:08, 1 year 4 months ago EQS-Adhoc: H&R GmbH & Co. KGaA: Publishing of preliminary results H&R GmbH & Co. KGaA announces preliminary results for 2024, with EBITDA exceeding the previous year at EUR 94.8 million. Stable earnings despite 1.0% decrease in sales revenues EBITDA Preliminary Results Financial Year 2024 H&R GmbH & Co. KGaA Sales Revenues
BRIEF published on 11/14/2024 at 09:36, 1 year 7 months ago H&R GmbH & Co. KGaA publie des résultats financiers mitigés pour le troisième trimestre 2024 Chiffre D'affaires Incertitudes Du Marché H&R GmbH Performances De L'EBITDA Résultats Du 3ème Trimestre 2024
BRIEF published on 11/14/2024 at 09:36, 1 year 7 months ago H&R GmbH & Co. KGaA Reports Mixed Financial Results for Q3 2024 Sales Revenue Market Uncertainties EBITDA Performance H&R GmbH Q3 2024 Results
PRESS RELEASE published on 11/14/2024 at 09:31, 1 year 7 months ago H&R GmbH & CO. KGaA publishes Nine-Months Quarterly Report 2024 H&R GmbH & Co. KGaA publishes Nine-Months Quarterly Report 2024, reporting highest operating earnings of EUR 24.8M in Q3 2024 EBITDA Earnings Q3 2024 H&R GmbH Nine-Months Quarterly Report
BRIEF published on 10/18/2024 at 10:26, 1 year 8 months ago H&R GmbH & Co. KGaA publie ses résultats préliminaires pour les neuf premiers mois de 2024 Chiffre D'affaires EBITDA Flux De Trésorerie D'exploitation Chiffres Sur Neuf Mois RAFFINAGE ChemPharm
BRIEF published on 10/18/2024 at 10:26, 1 year 8 months ago H&R GmbH & Co. KGaA Releases Preliminary Nine-Month Figures for 2024 EBITDA Operating Cash Flow Sales Revenues Nine-month Figures ChemPharm REFINING
PRESS RELEASE published on 10/18/2024 at 10:21, 1 year 8 months ago EQS-Adhoc: H&R GmbH & Co. KGaA: Publishing of preliminary figures for nine month period and third quarter 2024 H&R GmbH & Co. KGaA releases preliminary figures for third quarter and nine-month period of 2024, showing stable sales and earnings development. EBITDA at EUR 65.9 million EBITDA 2024 Preliminary Figures H&R GmbH & Co. KGaA Sales Revenues
Published on 06/30/2026 at 00:05, 1 hour 4 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 1 hour 23 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 3 hours 8 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 10 hours 9 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 10 hours 9 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 22:47, 2 hours 22 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 3 hours 4 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 3 hours 4 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 4 hours 39 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 5 hours 9 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 6 hours 39 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 6 hours 39 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 7 hours 24 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 7 hours 24 minutes ago Déclaration hebdomadaire de rachat d'actions
